IS
IS · IS · IS-EU/1/17/1193/004
Refixia
ATC B02BD04
Last synced from Icelandic Medicines Agency (Iceland) on
Identification
ManufacturerNovo Nordisk A/S*
CountryIS (IS)
ATC codeB02BD04
Dispensing—
ReimbursedNo
SourceIcelandic Medicines Agency (Iceland)
Last synced6/9/2026
Packs · 0
No packs registered.
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Stungulyfsstofn og leysir, lausn",
"source": "lyfjastofnun",
"atc_raw": "B02BD04",
"marketed": false,
"strength": "3000 a.e.",
"ma_number": "EU/1/17/1193/004",
"substance": "Nonacogum beta pegolum INN",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í blóðsjúkdómum og blóðsjúkdómum barna.",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "44907"
}Related drugs
Other records sharing ATC code B02BD04.
- NOAlprolixSwedish Orphan Biovitrum International AB
- 🇨🇭Alprolix
- ISAlprolix*Swedish Orphan Biovitrum AB (publ)
- ISAlprolix*Swedish Orphan Biovitrum AB (publ)
- ISAlprolix*Swedish Orphan Biovitrum AB (publ)
- ISAlprolix*Swedish Orphan Biovitrum AB (publ)
- ISAlprolix*Swedish Orphan Biovitrum AB (publ)
- PLAlprolixSwedish Orphan Biovitrum AB
Access this data programmatically
Query Refixia and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.